6
3
3
Restoring Confidence in the World Anti-Doping Agency Act of 2025
3/3/2026, 9:26 PM
Summary of Bill S 233
Bill 119 s 233, also known as the "Office of National Drug Control Policy Reauthorization Act of 2006 Amendment," aims to make changes to the authority of the Office of National Drug Control Policy (ONDCP) in relation to the World Anti-Doping Agency (WADA). The bill seeks to modify the ONDCP's role and responsibilities with regards to WADA, as well as address other related issues.
The Office of National Drug Control Policy was established in 1988 to coordinate drug control policy and activities within the federal government. The World Anti-Doping Agency, on the other hand, is an independent agency that aims to promote, coordinate, and monitor the fight against doping in sports internationally.
The specific changes proposed in Bill 119 s 233 are not explicitly outlined in the summary, but it is clear that the bill seeks to amend the 2006 reauthorization of the ONDCP in order to better align its authority and actions with those of WADA. Additionally, the bill states that it aims to address "other purposes," which could potentially include additional measures related to drug control policy and anti-doping efforts. Overall, Bill 119 s 233 appears to be focused on enhancing the ONDCP's role in combating doping in sports and ensuring that its actions are in line with international standards set by WADA. The bill is currently under consideration in Congress and may undergo further revisions before potentially becoming law.
The Office of National Drug Control Policy was established in 1988 to coordinate drug control policy and activities within the federal government. The World Anti-Doping Agency, on the other hand, is an independent agency that aims to promote, coordinate, and monitor the fight against doping in sports internationally.
The specific changes proposed in Bill 119 s 233 are not explicitly outlined in the summary, but it is clear that the bill seeks to amend the 2006 reauthorization of the ONDCP in order to better align its authority and actions with those of WADA. Additionally, the bill states that it aims to address "other purposes," which could potentially include additional measures related to drug control policy and anti-doping efforts. Overall, Bill 119 s 233 appears to be focused on enhancing the ONDCP's role in combating doping in sports and ensuring that its actions are in line with international standards set by WADA. The bill is currently under consideration in Congress and may undergo further revisions before potentially becoming law.
Congressional Summary of S 233
Restoring Confidence in the World Anti-Doping Agency Act of 2025
This bill requires the Office of National Drug Control Policy (ONDCP) to annually evaluate the governance and procedures of the World Anti-Doping Agency (WADA).
Specifically, the ONDCP, in consultation with the United States Anti-Doping Agency, the United States Olympic and Paralympic Committee, the Athletes' Advisory Council (Team USA AC), must determine whether WADA
- has a credible and independent governance model that provides for fair representation of the United States;
- fully implements or has implemented governance reforms to ensure independent governance; and
- has fair processes and procedures for selecting independent athletes for decision-making roles on the WADA Executive Committee, the WADA Foundation Board, and relevant expert advisory groups, standing committees, permanent special committees, and working groups of WADA.
If the ONDCP determines WADA has not met these criteria, the ONDCP must use all available tools and efforts to bring WADA into compliance with them.
Further, upon such a determination, the ONDCP may withhold up to the full amount of the United States' membership dues to WADA.
Read the Full Bill
Current Status of Bill S 233
Bill S 233 is currently in the status of Bill Introduced since January 23, 2025. Bill S 233 was introduced during Congress 119 and was introduced to the Senate on January 23, 2025. Bill S 233's most recent activity was Placed on Senate Legislative Calendar under General Orders. Calendar No. 340. as of February 23, 2026
Bipartisan Support of Bill S 233
Total Number of Sponsors
1Democrat Sponsors
0Republican Sponsors
1Unaffiliated Sponsors
0Total Number of Cosponsors
10Democrat Cosponsors
6Republican Cosponsors
4Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill S 233
Primary Policy Focus
Sports and RecreationAlternate Title(s) of Bill S 233
A bill to amend the Office of National Drug Control Policy Reauthorization Act of 2006 to modify the authority of the Office of National Drug Control Policy with respect to the World Anti-Doping Agency, and for other purposes.
A bill to amend the Office of National Drug Control Policy Reauthorization Act of 2006 to modify the authority of the Office of National Drug Control Policy with respect to the World Anti-Doping Agency, and for other purposes.
Comments
Sponsors and Cosponsors of S 233
Latest Bills
TRAPS Act
Bill HR 4936September 18, 2026
Apples to Apples Comparison Act of 2025
Bill HR 4093September 18, 2026
American Lending Fairness Act of 2026
Bill HR 7866September 18, 2026
Civil Investigative Demand Reform Act of 2025
Bill HR 1653September 18, 2026
American Reserve Modernization Act of 2026
Bill HR 8957September 18, 2026
Preventive Health Savings Act
Bill HR 4464September 18, 2026
PEARL Act
Bill HR 9327September 18, 2026
Medically Tailored Home-Delivered Meals Program Pilot Act
Bill HR 5439September 18, 2026
To designate the facility of the United States Postal Service located at 117 West Lovett Street in Charlotte, Michigan, as the "Francis C. Flaherty Post Office Building".
Bill HR 9570September 18, 2026
To designate the facility of the United States Postal Service located at 1019 Avenue H in Fort Madison, Iowa, as the "Martin L. Graber Post Office".
Bill HR 4707September 18, 2026
To amend the Office of National Drug Control Policy Reauthorization Act of 2006 to modify the authority of the Office of National Drug Control Policy with respect to the World Anti-Doping Agency, and for other purposes.
Bill HR 693January 24, 2025





